Literature DB >> 8652386

Tretinoin induces bone marrow collagenous fibrosis in acute promyelocytic leukaemia: new adverse, but reversible effect.

K Hatake1, T Ohtsuki, M Uwai, H Takahashi, T Izumi, M Yoshida, N Kanai, K Saito, K Harigaya, Y Miura.   

Abstract

In 11/13 acute promyelocytic leukaemia (APL) cases treated with tretinoin (RA) we observed RA-induced inaspirable collagenous fibrosis of the bone marrow. To study the mechanism of RA on collagen production, we cultured a human bone marrow derived stromal cell line and an osteoblastic cell line with RA in vitro. 10(-7) and 10(-6)M of RA stimulated collagen production. Clinical and experimental observation may be important to understand this adverse effect of RA as it is useful in cancer chemoprevention as well as treatment for APL. This adverse effect is spontaneously reversible after stopping RA or following chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652386     DOI: 10.1046/j.1365-2141.1996.d01-1708.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy.

Authors:  S Venkatesan; Abhishek Purohit; Ankur Ahuja; Dinesh Chandra; Mukul Aggarwal; R Amrita; Ravi Kumar; Manoranjan Mahapatra; Hara P Pati; Seema Tyagi
Journal:  Leuk Res Rep       Date:  2015-07-15

Review 2.  Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.

Authors:  Mengyu Xiao; Ling Qin; Xiaona Niu; Pan Zhou; Junwei Niu; Shengjie Wei; Dan Li; Liurui Dou; Wanjun Zhang; Lei Zhang; Kai Sun; Yanliang Bai
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

3.  Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia.

Authors:  Yuta Inagawa; Yukiko Komeno; Satoshi Saito; Yuji Maenohara; Tetsuro Yamagishi; Hiroyuki Kawashima; Taku Saito; Keiko Abe; Kuniko Iihara; Yasumasa Hatada; Tomiko Ryu
Journal:  Case Rep Hematol       Date:  2019-11-27

4.  Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.

Authors:  Suk-Hyun Hong; Melita Dvorak-Ewell; Hazel Y Stevens; Grant D Barish; Glenda L Castro; Russell Nofsinger; John A Frangos; Dolores Shoback; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.